Exam 1 Flashcards

1
Q

Food & Drug Administration (FDA)

A
  • Responsible for protecting public hlth by ensuring safety, efficacy, & security of drugs, biological products & medical devices
  • Ensure safety of nation’s food supply, cosmetics, & products tht emit radiation & more
  • Drug approval process tightly controlled by FDA; takes several yrs & phases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Preclinical Investigational Studies

A

Tested on laboratory animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Phase I Studies of FDA

A
  • Tested on hlthy human volunteers
  • Dose range & pharmacokinetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Phase II Studies of FDA

A
  • Tested on clients w/ disease
  • Therapeutic effects & adverse effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phase III Studies of FDA

A
  • Large sample size; placebo and/or blinded studies
    > effectiveness, safety, dose
  • Submission of new drug application; approved by FDA & given name; patent 5-7yrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Phase IV Studies of FDA

A
  • Post marketing studies (2+yrs)
  • New or severe adverse effects
  • Black box or recall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Legal Regulation of Drugs: Drug Enforcement Agency (DEA)

A
  • Regulates manufacturing, distribution, & dispensing of drugs w/ known abuse potential (controlled substances)
  • Anyone convicted of unlawfully manufacturing, distributing, or dispensing of controlled substances faces severe penalties
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Schedule I Controlled Substance

A
  • High abuse potential & no accepted medical use
  • Heroin, LSD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Schedule II Controlled Substances

A
  • High abuse potential w/ severe dependence liability
  • Opioids, amphetamines, barbiturates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Schedule III Controlled Substances

A
  • Less abuse potential & dependence liability than II (moderate)
  • Nonamphetamines stimulates, nonbarbiturates sedatives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Schedule IV Controlled Substances

A
  • Less abuse potential & dependence liability than III (moderate)
  • Antianxiety agents, some sedative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Schedule V Controlled Substances

A
  • Limited abuse potential
  • Codeine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pharmacology & the Nursing Process

A
  • Assessment
    > allergies: ask reaction - true allergy vs. adverse effect
    > medications: current & recent past, OTC, herbals, supplements
  • Diagnosis
  • Planning
    > expected outcomes SMART
  • Implementation/Interventions
    > administering medication
    > pt education
  • Evaluation
    > safe & effective med admin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

National Coordinating Council for Medication Error Reporting and Prevention definitions

A
  1. No error, although circumstances or events occurred tht could have led to error
  2. Medication error caused no harm
  3. Medication error that causes harm
  4. Medication error that results in death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most common cause of morbidity and preventable death in hospitals

A
  • Medication Errors
  • Nurse is last line of defense to prevent errors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Errors in Patient Assessment

A
  • Most common medication error
  • Inadequate medication or medical history
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Errors in Prescribing

A
  • Most common medication error
  • Wrong drug, incorrect dose, illegible written order
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Errors in Administration

A
  • Most common medication error
  • One of the “rights” of administration compromised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Distracting Environmental Factors and Stress

A
  • Most common medication error
  • Interruptions during preparation or administration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Prevention of Medication Errors

A
  • Proper assessment, administration, monitoring, evaluation, & documentation
  • Question a med order for any reason when in doubt
  • Always listen if pt questions drug
  • Don’t use med abbreviations & acronyms
  • Minimize telephone orders: use “read back” order to prescriber, spell drug name
  • Be careful w/ look alike, sound alike drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Reporting Medication Errors

A
  • Student: notify clinical faculty/RN immediately
  • Nurse:
    > notify PCP for additional orders
    > monitor, intervene as prescribed/appropriate
    > report (legal & ethical responsibility)
  • Improve systems & procedures; reduce future errors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Possible Consequences of Medication Errors

A
  • Psychological impact
  • Loss of trust
  • Named defendants in malpractice litigation; financial implications
  • Administrative response:
    > continuing education or refresher
    > discipline - suspension or termination
  • Board of Nursing
    > suspend or revoke license
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pharmacokinetics 4 Processes

A
  • Absorption: getting drug to blood
  • Distribution: getting drug to tissues/organs
  • Metabolism: breaking drug down
  • Excretion: getting drug out of body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pharmacokinetics

A

What the body does to the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Absorption - Pharmacokinetics

A
  • Getting drug to blood to be distributed to tissues
  • Factors Influencing Absorption:
    > Route
    > Drug properties: molecular size, lipid solubility, pH
    > Pt properties: surface area of absorptive surface, blood flow to site of absorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Oral Route in Absorption

A
  • Some meds absorbed in stomach, most in sm intestine
  • Due to first-pass metabolism, the onset of action for most oral drugs is 30-60 mins
  • 0-70% bioavailable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Factors Affecting Absorption via Oral Route

A
  • Molecular weight: too big, can’t pass membrane
  • Lipid solubility: sm & highly lipid soluble drugs rapidly thru membrane
  • Surface area of gastrointestinal mucosa
  • Blood flow to gastrointestinal syst
  • Rate of gastric emptying
  • Oral preparation
  • Admin of mult drugs simultaneously (interaction)
  • Foods & fluids admind w/ drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Distribution - Pharmacokinectics

A
  • Movement of drug to body’s tissue
  • Results in therapeutic and adverse effects
29
Q

Factors Influencing Distribution

A
  • Blood flow to organs/tissues
    > areas of rapid perfusion/distribution: heart, liver, kidney, brain
    > Areas of slow distribution: muscle, skin, fat
  • Ability to cross blood-brain barrier or fetal/placental barrier
  • Drug Properties:
    > Protein binding (albumin): highly protein bound = less available for distribution
    > Water solubility vs lipid solubility: highly water-soluble drugs stay in blood stream; go more places. highly lipid-soluble drugs more readily pass lipid cell membs & deposit in adipose tissue
30
Q

Metabolism (biotansformation) - Pharmacokinetics

A
  • Liver is primary site: hepatic microsomal enzyme syst
  • Metabolic activity may be dcrd in some pts
    > infants & elderly, genetic disorders, severe liver disease
    > dosage reduced in dcrd liver func to prevent toxicity
  • Liver transforms some drugs to active form (prodrug)
  • Nurse: liver disease is a caution/contraindication when admining certain drugs, moniter liver func to avoid drug toxicity or injury to liver
31
Q

Enzyme Induction

A
  • Incrd activity of enzyme syst by presence of 1st drug; speeds metabolism of 2nd drugs using same enzyme syst; can’t reach needed therapeutic lvls
  • Why some drugs can’t be taken together
32
Q

Enzyme Inhibited

A
  • Some drugs inhibit enzyme syst & make it less effective
  • Drug will not be broken down for excretion
  • Blood lvl of drug incrs to toxic lvl
33
Q

First Pass Effect

A
  1. Oral drug taken by pt
  2. Drug absorbed across the intestinal mucosa
  3. Drug enters portal circulation & travels to liver
  4. On first pass thru liver, drug is metabolized to less active forms
  5. Drug metabolites (less active) leave the liver for distribution to tissues
34
Q

Excretion - Pharmacokinetics

A
  • Kidneys are primary organ for excretion of drugs from body
  • Liver/bowel are secondary site for excretion
    > drugs processed by liver, released into bile, eliminated in feces
  • Kidney dysfunc: drugs not excreted effectively, reach toxic lvls
  • Nurse: monitor kidney func to avoid drug toxicity or AKI
35
Q

Onset

A

Time for a drug to elicit a therapeutic response

36
Q

Peak

A

Time for a drug to reach its maximum therapeutic response

37
Q

Duration

A

Time for a drug concentration to sufficiently elicit therapeutic response

38
Q

Therapeutic Minimal Effective Concentration (MEC)

A
  • Amnt of a drug tht is needed to cause a therapeutic effect
  • Recommended dose of a drug is based on amnt tht must be given to eventually reach therapeutic MEC
  • Too much drug = toxic (poisonous) effects
  • Too little drug = will not produce desired therapeutic effects
39
Q

Loading Dose

A
  • Higher dose than usually used for treatment to reach therapeutic MEC faster
  • Subsequently maintained by using recommended dosing schedule
40
Q

Half-Life

A
  • Time required for one-half (50%) of a given drug to be removed from the body
  • Greater half-life, longer it takes to excrete
  • Determines frequency & dosage
41
Q

How Drug Attains & Maintains Therapeutic Range (steady state)

A
  • Repeated doses of a drug are given
  • Drug accumulated in bloodstream
  • Plateau is reached
  • Amnt admind equals amnt eliminated
42
Q

Therapeutic Drug Monitoring

A
  • Blood test performed to determine lvls of drugs
    > Determine therapeutic range & avoid toxicity
  • Peak & Trough
    > Tests to determine highest & lowest blood lvl of drug
43
Q

Trough (Peak&Trough)

A

Lowest drug lvl needed to reach therapeutic range drawn 1 hr prior to start of next infusion

44
Q

Peak (Peak&Trough)

A

Highest lvl of the drug in the bloodstream drawn 1 hr after infusion completed

45
Q

Factors Influencing Drugs Effects

A
  • Age
  • Gender
    > men more vascular muscles
    > women more fat cells; slow release
  • Physiological: hydration, acid-base, electrolytes
  • Pathological: disorders change conditions for drug (vascular, GI, liver, kidney disease)
  • Genetic: lack enzymes, cultural diffs
  • Psychological: attitude; placebo effect, trust in HCP
  • Environmental: temp, relaxed
  • Tolerance: larger dose needed
  • Interactions: two or more drugs
46
Q

Drug-Drug Interactions

A
  • Site of absorption: one drug prevents or accelerate absorption of another drug
  • During distribution/site of action
    > drugs compete for binding site of another, one drug gets bumped off
    > opposing mechanisms of actions
    > drugs w/ similar adverse effects
  • During metabolism: one drug stimulated or block metabolism of another
  • During excretion: one drug competes for other to be excreted. leads to accumulation/toxicity
47
Q

Drug-Food Interactions

A
  • Prevent absorption (oral route)
    > incrd acid production, speeds breakdown of drug
    > milk products: calcium binds drug, dcrd absorption
    > chemical reaction
  • Incr or dcr drug’s effect (any route)
    > food affects liver enzyme: grapefruit juice inhibits liver enzymes leading to toxic effects
48
Q

Types of Adverse Effects/Reactions

A
  • Primary actions (pharmacological)
    > overdose; extension of desired effect (antihypertensive, hypotension) - dose adjustments
  • Secondary actions
    > undesired effects produced in addition to pharmacologic effect (antihypertensive, nausea, diarrhea, rash) - undesired effect must be tolerated
  • Toxicity
  • Allergic reactions
49
Q

Allergic Reactions: Nursing Intervention

A
  • 1st:
    > stop admind of med immediately
    > apply oxygen if needed
  • Next:
    > call rapid response team if severe
    > notify PCP
    > Admin IV fluids as ordered
    > Admin antihistamines as ordered
50
Q

Pharmacodynamics

A
  • How the medication affects the body
  • Drugs act at specific areas on cell membs called receptor sites
    > normally bind hormones, neurotransmitters, growth factors
  • Drugs change existing physiological & biochemical processes
51
Q

Medications work in 1 of 4 ways (pharmacodynamics)

A
  1. To replace or act as substitutes for missing chemicals
  2. To incr or stimulate certain cellular activities
  3. To depress or slow cellular activities
  4. To interfere w/ the funcing of foreign cells, such as invading microorganisms or neoplasms lead to cell death
52
Q

Agonist (Receptor Theory Type)

A
  • Drugs interact directly w/ receptor sites
  • Cause same activity of natural chemicals would case at tht site
  • EX: insulin; beta-agonist
53
Q

Antagonist (Receptor Theory Type)

A
  • Competitive: block normal stimulation of receptor
  • Noncompetitive: prevent reaction of another chemical w/ a diff receptor site on cell
  • EX: beta-blockers; anti-histamines
54
Q

Cholinergic Agonist

A
  • Parasympathetic branch
  • Mimics acetylcholine
  • Incrs saliva production
  • Slows HR
  • Constricts bronchioles
  • Stims digestive process
  • Incrs urination
  • Common use: Alzheimer’s disease
55
Q

Cholinergic-Blocking

A
  • Parasympathetic branch
  • Anti-cholinergic
  • Dcrs saliva/secretion
  • Incrs HR
  • Relaxes bronchioles
  • Dcrd GI motility & peristalsis
  • Urinary retention
  • Drowsiness, disorientation
  • Uses: bowel & bladder disorder, Parkinson’s disease, asthma
56
Q

Cholinergic Mnemonic - SLUDGE

A

S = salivation
L = lacrimation
U = urination
D = diaphoresis (sweating)
G = GI upset
E = emesis (vomiting)

57
Q

Anticholinergic Mnemonic

A
  • Can’t SEE / dry eyes, blurred vision
  • Can’t PEE / urinary retention
  • Can’t SPIT / dry mouth
  • Can’t SHIT / constipation
58
Q

Adrenergic Agonist

A
  • Sympathetic branch
  • Tachycardia & vasoconstriction
  • Bronchodilation
  • Dcrd GI motility
  • Glycogenolysis (incrd bld glucose)
  • Constricts bladder sphincter
  • Uses: cardiac & respiratory
  • Sympathomimetic
    (think of switching the fight or flight ON)
59
Q

Adrenergic Antagonist (adrenergic-blocking)

A
  • Sympathetic branch
  • Slows HR
  • Lowers BP
  • Bronchoconstriction
  • Masks s/s hypoglycemia
  • Urinary incontinence
  • Uses: HTN, BPH
  • alpha-, beta- blocker
60
Q

Anti-Inflammatory Drugs

A
  • Fluticasone (inhaler/nasal)
  • Montelukast
61
Q

Bronchodilator Drugs

A
  • Albuterol (inhaler)
  • Salmeterol (inhaler)
  • Ipratropium (inhaler)
  • Theophylline/aminophylline
62
Q

Inhaler Education

A
  • Correct administration procedure & return demonstration
  • Clean delivery devices weekly
  • Rinse mouth after inhaler use
    > esp w/ inhaled corticosteroid
  • Timing of ad ministration
    > prior to exercise, acute attack, daily use
  • Adverse effects of inhaled medication
63
Q

Sequencing of Multiple Inhalers

A
  1. Bronchodilators
    - Beta agonist agents
    > wat 1 min btwn puffs for mult inhalation of same med
    > wait 2-5 mins before administering next med
    - Anticholingeric agents
    > scheduled administration only (not rescue inhaler)
  2. Corticosteroids
    - Administer after bronchodilators
    - Wait 1 min btwn puffs for mult inhalations of same med
    - Rinse mouth following use (don’t swallow water) to prevent oropharyngeal fungal infection
64
Q

Albuterol

A

MOA: Beta2 selective adrenergic agonist; bronchodilator (SABA)
INDICATIONS: Acute bronchospasm (asthma attack, COPD exacerbation, pneumonia), prevention of exercise induced asthma
ROUTE: inhaler, nebulizer; onset 5-15 mins
CONTRAINDICATIONS: conditions exacerbated by sympathymimetic effects
DRUG-DRUG: beta adrenergic antagonist
AE: sympathomimetic stimulation; cardiac arrhythmias, HTN, sweating, tremors; worsened bronchospasm
NURSING: admin for symps or scheduled; overuse incrs AE; use 30-60 min prior to exercise

65
Q

Salmeterol (Servant Diskus)

A

MOA: Beta2 selective adrenergic agonist; bronchodilation (LABA)
INDICATIONS: prevent exercise induced bronchospasm; COPD, asthma (maintenance)
ROUTE: inhaler
CONTRAINDICATIONS: condition exacerbation by sympathomimetic effects
BLACK BOX: incrd risk of asthma-related deaths; use inhaled corticosteroid to dcr risk
DRUG-DRUG: beta-adrenergic antagonists
AE: same as SABA
NURSING: NOT a rescue inhaler; admin on schedule

66
Q

Ipratropium (Atrovent)

A

(resp anticholinergic)
MOA: blocks acetylcholine (PSNS); airway dilation
INDICATION: prevention of bronchospasm (maintenance)
ROUTE: inhaler
AE: dry mouth, nasal congestion, heart palpitations; other systemic anticholinergic effects rare
NURSING: NOT a rescue inhaler

67
Q

Fluticason (Flovent)

A

(inhaled corticosteroid)
MOA: dcr inflammatory response in airways
INDICATIONS: prevention and treatment of asthma (maintenance)
ROUTE: inhaler
AE: sore throat, hoarseness, coughing, dry mouth, pharyngeal & laryngeal fungal infections; systemic rare
NURSING: assess mucous membs-fungal infection; educate pt: rinse mouth after, NOT a rescue inhaler

68
Q

Montelukast (Singulair)

A

(leukotriene receptor antagonist)
MOA: selectively block receptors for production of leukotrienes; reduces inflammation
INDICATIONS: prophylaxis for asthma in adults & children
ROUTE: oral
AE: mood & behavior changes
NURSING: NOT a rescue med; approved for use in children 1+

69
Q

Theophylline/Aminophylline

A

(xanthine derivatives)
MOA: direct effect on smooth muscles of respiratory tract. both in bronchi & bad vessels (metabolized to caffeine)
INDICATIONS: prevention (theophylline) or reversal of bronchospasm (aminophylline)
ROUTE: oral (theophylline) or IV (aminophylline)
CONTRAINDICATIONS: cardiovascular disease
AE: related to blood lvls: GI upset, nausea, irritability, & tachycardia to seizure, brain damage, & death
NURSING: narrow therapeutic window, monitor lvls; smoking incrs metabolism (lowers lvls)